Zeropecia Solution contains Minoxidil 5% w/v, a potent vasodilator indicated for the treatment of androgenetic alopecia in both men and women. Minoxidil promotes hair regrowth by enhancing follicular size and prolonging the anagen phase of the hair cycle, thereby increasing hair density and thickness. The topical formulation is applied directly to the scalp, ensuring targeted delivery to hair follicles. Clinical studies have demonstrated that Minoxidil 5% is more effective than lower concentrations in stimulating hair regrowth, with a favorable safety profile when used as directed. Patients should apply 1 ml of Zeropecia Solution twice daily to the affected scalp areas, ensuring the scalp is dry before application. Common adverse effects may include localized irritation, itching, dryness, or erythema at the application site; these are generally mild and transient. Systemic absorption is minimal, but caution is advised in patients with cardiovascular conditions due to Minoxidil’s vasodilatory effects. Zeropecia Solution is contraindicated in individuals with hypersensitivity to Minoxidil or any formulation components. Consistent use over a period of at least 4 months is recommended to evaluate efficacy, with continued application necessary to maintain hair regrowth. Discontinuation typically results in the reversal of therapeutic benefits.